{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T13:38:09Z","timestamp":1774013889163,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T00:00:00Z","timestamp":1400198400000},"content-version":"vor","delay-in-days":500,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/s10156-013-0617-6","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T14:18:01Z","timestamp":1369318681000},"page":"1042-1046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Susceptibility and emm type of Streptococcus pyogenes isolated from children with severe infection"],"prefix":"10.1016","volume":"19","author":[{"given":"Hiroshi","family":"Sakata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-013-0617-6_bib0005","series-title":"Approved Standard M07\u2013A8","article-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically","year":"2009"},{"key":"10.1007\/s10156-013-0617-6_bib0010","series-title":"Methods for determining bactericidal activity of antimicrobial agents; Approved guideline. M26-A","year":"1999"},{"key":"10.1007\/s10156-013-0617-6_bib0015","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1099\/jmm.0.2008\/002642-0","article-title":"Distribution of emm type and antibiotic susceptibility of group A streptococci causing invasive and noninvasive disease","volume":"57","author":"Wajima","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1007\/s10156-013-0617-6_bib0020","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2165\/11634180-000000000-00000","article-title":"Invasive group a streptococcal disease: epidemiology, pathogenesis and management","volume":"72","author":"Steer","year":"2012","journal-title":"Drugs"},{"key":"10.1007\/s10156-013-0617-6_bib0025","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3201\/eid15\/2.080558","article-title":"Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005\u20132007","volume":"15","author":"Steer","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1007\/s10156-013-0617-6_bib0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1442-200X.2007.02378.x","article-title":"Clinical and epidemiologic features of invasive group A streptococcal infections in children","volume":"49","author":"Mulla","year":"2007","journal-title":"Pediatr Int"},{"key":"10.1007\/s10156-013-0617-6_bib0035","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10096-009-0854-x","article-title":"Invasive group A streptococcal infection in children: clinical manifestations and molecular characterization in a French pediatric tertiary care center","volume":"29","author":"Henriet","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1007\/s10156-013-0617-6_bib0040","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s10096-011-1226-x","article-title":"Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998\u20132009): comparison with non-invasive isolates","volume":"30","author":"Montes","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1007\/s10156-013-0617-6_bib0045","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1574-695X.2010.00652.x","article-title":"Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003\u20132007","volume":"58","author":"Im\u00f6hl","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1007\/s10156-013-0617-6_bib0050","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10096-010-0989-9","article-title":"Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland","volume":"29","author":"Siljander","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1007\/s10156-013-0617-6_bib0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/421949","article-title":"Group A streptococcal pharyngitis serotype surveillance in North America, 2000\u20132002","volume":"39","author":"Shulman","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1007\/s10156-013-0617-6_bib0060","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3201\/eid1711.110159","article-title":"Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002\u20132010","volume":"17","author":"Shea","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1007\/s10156-013-0617-6_bib0065","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/IAI.68.6.3523-3534.2000","article-title":"Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases","volume":"68","author":"Chatellier","year":"2000","journal-title":"Infect Immun"},{"key":"10.1007\/s10156-013-0617-6_bib0070","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1099\/jmm.0.042309-0","article-title":"Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children","volume":"61","author":"Liang","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1007\/s10156-013-0617-6_bib0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0732-8893(86)90069-6","article-title":"Penicillin tolerant group A streptococci","volume":"4","author":"Krasinski","year":"1986","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1007\/s10156-013-0617-6_bib0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/978-1-4899-1825-3_107","article-title":"Guidelines for detection of penicillin tolerance in Streptococcus pyogenes by MIC-MBC method","volume":"418","author":"Van Asselt","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1007\/s10156-013-0617-6_bib0085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jac\/dkf174","article-title":"Clinical significance of inhibition kinetics for Streptococcus pyogenes in response to penicillin","volume":"50","author":"Steininger","year":"2002","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1007\/s10156-013-0617-6_bib0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0022-3476(85)80392-9","article-title":"Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis","volume":"107","author":"Kim","year":"1985","journal-title":"J Pediatr"},{"key":"10.1007\/s10156-013-0617-6_bib0095","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/BF01968144","article-title":"Association of penicillin-tolerant streptococci with epidemics of streptococcal pharyngitis in closed communities","volume":"8","author":"Dagan","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1007\/s10156-013-0617-6_bib0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0002-9343(52)90293-3","article-title":"Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice","volume":"13","author":"Eagle","year":"1952","journal-title":"Am J Med"},{"key":"10.1007\/s10156-013-0617-6_bib0105","unstructured":"EUCAST Definitive Document E. Def 1.2, May 2000: Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Dieases (ESCMID) Clin Microbiol Infect 2000;6 503-8."},{"issue":"1","key":"10.1007\/s10156-013-0617-6_bib0110","first-page":"32","article-title":"In vivo and in vitro antibacterial activity of doripenem","volume":"53","author":"Nishino","year":"2005","journal-title":"Jpn J Chemotherapy"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X13700059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X13700059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10156-013-0617-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:49:12Z","timestamp":1761158952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X13700059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1341321X13700059"],"URL":"https:\/\/doi.org\/10.1007\/s10156-013-0617-6","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibility and emm type of Streptococcus pyogenes isolated from children with severe infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-013-0617-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}